COP
50
8
CMS
65
5
CHK
12
9
NRG
65
3
F
46
4
EOG
49
4
GWW
44
-2
EQIX
45
-5
DUK
64
5
AAP
26
2
WAT
32
-4
FITB
50
2
ILMN
30
-6
IFF
59
5
M
31
4
MOS
29
7
ACN
42
-16
SYY
57
4
REGN
68
3
NUE
37
-2
COP
50
8
CMS
65
5
CHK
12
9
NRG
65
3
F
46
4
EOG
49
4
GWW
44
-2
EQIX
45
-5
DUK
64
5
AAP
26
2
WAT
32
-4
FITB
50
2
ILMN
30
-6
IFF
59
5
M
31
4
MOS
29
7
ACN
42
-16
SYY
57
4
REGN
68
3
NUE
37
-2
Financhill
Back

Mid-America Apartment Communities Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
38

MAA
Mid-America Apartment Communities

Last Price:
141.15
Seasonality Move:
1.32%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
38
Mid-America Apartment Communities (MAA) is a Sell

Is Mid-America Apartment Communities a Buy, Sell or Hold?

  • The current Mid-America Apartment Communities [MAA] share price is $143.32. The Score for MAA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MAA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MAA Stock Price Chart

What is Mid-America Apartment Communities's stock price today?

  • The Mid-America Apartment Communities share price today is $143.32
    The current trend is moderately bullish and MAA is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

MAA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.14 Buy
Relative Strength Index (14 RSI): 69.11 Buy
Chaikin Money Flow: 305518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (132.96 - 140) Buy
Bollinger Bands (100): (126.5 - 136.02) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

MAA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 139.99 Buy
20-day SMA: 136.6 Buy
50-day SMA: 133.75 Buy
200-day SMA: 130.41 Buy
8-day EMA: 140.27 Buy
20-day EMA: 137.95 Buy
50-day EMA: 135.07 Buy
200-day EMA: 134.67 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

Mid-America Apartment Communities Earnings Growth & MAA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.02 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Mid-America Apartment Communities Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):